English

Bio-AMD Inc.

EDGAR

Quarterly report (10-Q) · filed 2016-11-15

50 filing records in this dataset, filed from 2007-04-17 to 2016-11-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2015 Q4 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-320 thousand USD

2015 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -254973 USD Source
Operating Cash Flow: 65312 USD Source

Free cash flow

-320 thousand USD

2015 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -254973 USD Source
Operating Cash Flow: 65312 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 123 thousand USD 2016-09-30 Source
Exact value

122952 USD
Long-term debt including current maturities: Not available
Shares outstanding: 46 million shares 2016-09-30 Source
Exact value

45975966 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

45975966 shares · 2015-09-30· Source
45975966 shares · 2016-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Revenue: 0 USD · 2015-01-01 – 2015-03-31 Source
Revenue: 0 USD · 2015-04-01 – 2015-06-30 Source
Revenue: 0 USD · 2015-07-01 – 2015-09-30 Source
Revenue: 0 USD · 2015-01-01 – 2015-12-31 Source
Revenue: 0 USD · 2015-01-01 – 2015-09-30 Source

Net income

-248 thousand USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Net income: -830973 USD · 2015-01-01 – 2015-12-31 Source
Net income: -659213 USD · 2015-01-01 – 2015-09-30 Source
Net income: -153275 USD · 2016-01-01 – 2016-03-31 Source
Net income: 144717 USD · 2016-04-01 – 2016-06-30 Source
Net income: -67660 USD · 2016-07-01 – 2016-09-30 Source

Operating cash flow

-709 thousand USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Operating cash flow: -254973 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: 65312 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -209341 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -341749 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -209341 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -388225 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -341749 USD · 2016-01-01 – 2016-06-30 Source

Capital expenditure

0 USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 0 USD · 2015-04-01 – 2015-06-30 Source
Capital expenditure: 0 USD · 2015-07-01 – 2015-09-30 Source
Capital expenditure: 0 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 0 USD · 2015-01-01 – 2015-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-11-15.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2015-12-31
Operating income: 6 of 11 periods available· newest 2015-12-31
Net income: 4 of 11 periods available· newest 2015-12-31
Operating cash flow: 7 of 11 periods available· newest 2015-12-31
Capital expenditure: 7 of 11 periods available· newest 2015-12-31
Total assets: 7 of 11 periods available· newest 2015-12-31
Total liabilities: 7 of 11 periods available· newest 2015-12-31
Current assets: 7 of 11 periods available· newest 2015-12-31
Current liabilities: 7 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2015-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2014-01-01 – 2014-12-31
Current period

USD 0

2015-01-01 – 2015-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
0 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Bio-AMD Inc. · 2015-12-31 Bio-AMD Inc. (edgar:1370030) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#51859 Filing: 000118518516004058 Input fundies:Revenue: 0 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#51967 Filing: 000118518516004058
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 300,157

Prior period

−USD 1.13 million

2014-01-01 – 2014-12-31
Current period

−USD 830,973

2015-01-01 – 2015-12-31

Exact inputs and evidence

-830973 − -1131130 = 300157 USD

-1131130 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-830973 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Bio-AMD Inc. · 2015-12-31 Bio-AMD Inc. (edgar:1370030) Year-over-year change in Net income: 300157 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -830973 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#54377 Filing: 000118518516004058 Input fundies:NetIncome: -1131130 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#54501 Filing: 000118518516004058
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 918,274

Prior period

−USD 1.17 million

2014-01-01 – 2014-12-31
Current period

−USD 254,973

2015-01-01 – 2015-12-31

Exact inputs and evidence

-254973 − -1173247 = 918274 USD

-1173247 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-254973 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Bio-AMD Inc. · 2015-12-31 Bio-AMD Inc. (edgar:1370030) Year-over-year change in Operating cash flow: 918274 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -254973 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#69887 Filing: 000118518516004058 Input fundies:OperatingCashFlow: -1173247 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#70109 Filing: 000118518516004058
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
USD 0

Prior period

USD 0

2014-01-01 – 2014-12-31
Current period

USD 0

2015-01-01 – 2015-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
0 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Bio-AMD Inc. · 2015-12-31 Bio-AMD Inc. (edgar:1370030) Year-over-year change in Capital expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#657529 Filing: 000118518516004058 Input fundies:CapitalExpenditure: 0 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#660917 Filing: 000118518516004058
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 0
Operating costs Derived USD 911,423
Operating income −USD 911,423
Tax, interest and other Derived −USD 80,450
Net income −USD 830,973

Cash

Operating cash flow −USD 254,973
Capital expenditure USD 0
Free cash flow Derived −USD 254,973

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.
2011 Not shown: operating income or net income is not reported.
2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2015 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2006-01-01 – 2006-12-31	Unavailable	Unavailable	Unavailable	-60905	Unavailable	Source 2006-01-01 – 2006-12-31: 0 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -60905 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -50905 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	2561623 Derived	-2561623	Unavailable	Unavailable	-2240738 Derived	Source 2010-01-01 – 2010-12-31: 0 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -2561623 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -2230909 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 9829 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	2892355 Derived	-2892355	Unavailable	Unavailable	-560941 Derived	Source 2011-01-01 – 2011-12-31: 0 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -2892355 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -550098 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 10843 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	1122082 Derived	-1122082	Unavailable	Unavailable	-1096369 Derived	Source 2012-01-01 – 2012-12-31: 0 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -1122082 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -1096369 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 0 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	1128566 Derived	-1128566	-134272 Derived	-994294	-1018458 Derived	Source 2013-01-01 – 2013-12-31: 0 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -1128566 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -994294 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -1018045 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 413 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	1195662 Derived	-1195662	-64532 Derived	-1131130	-1173247 Derived	Source 2014-01-01 – 2014-12-31: 0 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -1195662 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -1131130 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -1173247 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 0 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	911423 Derived	-911423	-80450 Derived	-830973	-254973 Derived	Source 2015-01-01 – 2015-12-31: 0 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -911423 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -830973 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -254973 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2015

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20062006-12-31	Revenue	Revenue: 0 Open source
20102010-12-31	Revenue	Revenue: 0 Open source
20112011-12-31	Revenue	Revenue: 0 Open source
20122012-12-31	Revenue	Revenue: 0 Open source
20132013-12-31	Revenue	Revenue: 0 Open source
20142014-12-31	Revenue	Revenue: 0 Open source
20152015-12-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20112011-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20122012-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20132013-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20142014-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20152015-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2006-12-31	Operating margin	Not reported	Revenue: 0 Open source
20102010-12-31	Operating margin	Not reported	Operating Income: -2561623 Open source Revenue: 0 Open source
20112011-12-31	Operating margin	Not reported	Operating Income: -2892355 Open source Revenue: 0 Open source
20122012-12-31	Operating margin	Not reported	Operating Income: -1122082 Open source Revenue: 0 Open source
20132013-12-31	Operating margin	Not reported	Operating Income: -1128566 Open source Revenue: 0 Open source
20142014-12-31	Operating margin	Not reported	Operating Income: -1195662 Open source Revenue: 0 Open source
20152015-12-31	Operating margin	Not reported	Operating Income: -911423 Open source Revenue: 0 Open source
20062006-12-31	Net margin	Not reported	Net Income: -60905 Open source Revenue: 0 Open source
2010-12-31	Net margin	Not reported	Revenue: 0 Open source
2011-12-31	Net margin	Not reported	Revenue: 0 Open source
2012-12-31	Net margin	Not reported	Revenue: 0 Open source
20132013-12-31	Net margin	Not reported	Net Income: -994294 Open source Revenue: 0 Open source
20142014-12-31	Net margin	Not reported	Net Income: -1131130 Open source Revenue: 0 Open source
20152015-12-31	Net margin	Not reported	Net Income: -830973 Open source Revenue: 0 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -50905 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2230909 Open source Capital Expenditure: 9829 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -550098 Open source Capital Expenditure: 10843 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1096369 Open source Capital Expenditure: 0 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1018045 Open source Capital Expenditure: 413 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1173247 Open source Capital Expenditure: 0 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -254973 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -255K 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Operating cash flow	-50905	Operating Cash Flow: -50905 Open source
20102010-12-31	Operating cash flow	-2230909	Operating Cash Flow: -2230909 Open source
20112011-12-31	Operating cash flow	-550098	Operating Cash Flow: -550098 Open source
20122012-12-31	Operating cash flow	-1096369	Operating Cash Flow: -1096369 Open source
20132013-12-31	Operating cash flow	-1018045	Operating Cash Flow: -1018045 Open source
20142014-12-31	Operating cash flow	-1173247	Operating Cash Flow: -1173247 Open source
20152015-12-31	Operating cash flow	-254973	Operating Cash Flow: -254973 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -255K 2015

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -50905 Open source
20102010-12-31	Free cash flow	-2240738	Operating Cash Flow: -2230909 Open source Capital Expenditure: 9829 Open source
20112011-12-31	Free cash flow	-560941	Operating Cash Flow: -550098 Open source Capital Expenditure: 10843 Open source
20122012-12-31	Free cash flow	-1096369	Operating Cash Flow: -1096369 Open source Capital Expenditure: 0 Open source
20132013-12-31	Free cash flow	-1018458	Operating Cash Flow: -1018045 Open source Capital Expenditure: 413 Open source
20142014-12-31	Free cash flow	-1173247	Operating Cash Flow: -1173247 Open source Capital Expenditure: 0 Open source
20152015-12-31	Free cash flow	-254973	Operating Cash Flow: -254973 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

82.7% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Liabilities / assets	4.6%	Total Liabilities: 74000 Open source Total Assets: 1615000 Open source
20102010-12-31	Liabilities / assets	8.6%	Total Liabilities: 386465 Open source Total Assets: 4472757 Open source
20112011-12-31	Liabilities / assets	1%	Total Liabilities: 39354 Open source Total Assets: 3987284 Open source
20122012-12-31	Liabilities / assets	1.3%	Total Liabilities: 40621 Open source Total Assets: 3031685 Open source
20132013-12-31	Liabilities / assets	2%	Total Liabilities: 40000 Open source Total Assets: 2043191 Open source
20142014-12-31	Liabilities / assets	5.7%	Total Liabilities: 50310 Open source Total Assets: 883711 Open source
20152015-12-31	Liabilities / assets	82.7%	Total Liabilities: 1053106 Open source Total Assets: 1274162 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.05× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Current assets / current liabilities	Not reported	Current Assets: 1613000 Open source Current Liabilities: 0 Open source
20102010-12-31	Current assets / current liabilities	11.44×	Current Assets: 4422894 Open source Current Liabilities: 386465 Open source
20112011-12-31	Current assets / current liabilities	100.52×	Current Assets: 3955933 Open source Current Liabilities: 39354 Open source
20122012-12-31	Current assets / current liabilities	73.28×	Current Assets: 2976842 Open source Current Liabilities: 40621 Open source
20132013-12-31	Current assets / current liabilities	48.86×	Current Assets: 1954304 Open source Current Liabilities: 40000 Open source
20142014-12-31	Current assets / current liabilities	14.92×	Current Assets: 750763 Open source Current Liabilities: 50310 Open source
20152015-12-31	Current assets / current liabilities	1.05×	Current Assets: 1108157 Open source Current Liabilities: 1053106 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−USD 60,905 Exact value Exact value: -60905 USD 2006-01-01 – 2006-12-31: -60905 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-AMD Inc. · 2006-12-31 Bio-AMD Inc. (edgar:1370030) Net Income: -60905 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -60905 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/0001013762-07-000832.txt#1751 The citation records this snapshot. The page link may show a newer release later.	−USD 50,905 Exact value Exact value: -50905 USD 2006-01-01 – 2006-12-31: -50905 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-AMD Inc. · 2006-12-31 Bio-AMD Inc. (edgar:1370030) Operating Cash Flow: -50905 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50905 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/0001013762-07-000832.txt#1830 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	Unavailable Not reported for this period.	Unavailable Not reported for this period.	USD 0 Exact value Exact value: 0 USD 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bio-AMD Inc. · 2009-12-31 Bio-AMD Inc. (edgar:1370030) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/0001185185-11-000349.txt#11215 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2010 2010-01-01 – 2010-12-31	Unavailable Not reported for this period.	−USD 2.23 million Exact value Exact value: -2230909 USD 2010-01-01 – 2010-12-31: -2230909 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-AMD Inc. · 2010-12-31 Bio-AMD Inc. (edgar:1370030) Operating Cash Flow: -2230909 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2230909 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518512000554/biad-20111231.xml#102271 Filing: 000118518512000554 The citation records this snapshot. The page link may show a newer release later.	USD 9,829 Exact value Exact value: 9829 USD 2010-01-01 – 2010-12-31: 9829 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bio-AMD Inc. · 2010-12-31 Bio-AMD Inc. (edgar:1370030) Capital Expenditure: 9829 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9829 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518512000554/biad-20111231.xml#102898 Filing: 000118518512000554 The citation records this snapshot. The page link may show a newer release later.	−USD 2.24 million Calculation and evidence -2230909 − 9829 USD Exact free cash flow: -2240738 USD 2010-01-01 – 2010-12-31: -2230909 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 9829 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bio-AMD Inc. · 2010-12-31 Bio-AMD Inc. (edgar:1370030) Free cash flow: -2240738 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2230909 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518512000554/biad-20111231.xml#102271 Filing: 000118518512000554 Input fundies:CapitalExpenditure: 9829 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518512000554/biad-20111231.xml#102898 Filing: 000118518512000554 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	Unavailable Not reported for this period.	−USD 550,098 Exact value Exact value: -550098 USD 2011-01-01 – 2011-12-31: -550098 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-AMD Inc. · 2011-12-31 Bio-AMD Inc. (edgar:1370030) Operating Cash Flow: -550098 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -550098 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518513000598/biad-20121231.xml#139682 Filing: 000118518513000598 The citation records this snapshot. The page link may show a newer release later.	USD 10,843 Exact value Exact value: 10843 USD 2011-01-01 – 2011-12-31: 10843 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bio-AMD Inc. · 2011-12-31 Bio-AMD Inc. (edgar:1370030) Capital Expenditure: 10843 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10843 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518513000598/biad-20121231.xml#140304 Filing: 000118518513000598 The citation records this snapshot. The page link may show a newer release later.	−USD 560,941 Calculation and evidence -550098 − 10843 USD Exact free cash flow: -560941 USD 2011-01-01 – 2011-12-31: -550098 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 10843 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bio-AMD Inc. · 2011-12-31 Bio-AMD Inc. (edgar:1370030) Free cash flow: -560941 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -550098 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518513000598/biad-20121231.xml#139682 Filing: 000118518513000598 Input fundies:CapitalExpenditure: 10843 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518513000598/biad-20121231.xml#140304 Filing: 000118518513000598 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	Unavailable Not reported for this period.	−USD 1.1 million Exact value Exact value: -1096369 USD 2012-01-01 – 2012-12-31: -1096369 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-AMD Inc. · 2012-12-31 Bio-AMD Inc. (edgar:1370030) Operating Cash Flow: -1096369 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1096369 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518514000677/biad-20131231.xml#153243 Filing: 000118518514000677 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2012-01-01 – 2012-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bio-AMD Inc. · 2012-12-31 Bio-AMD Inc. (edgar:1370030) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518514000677/biad-20131231.xml#153868 Filing: 000118518514000677 The citation records this snapshot. The page link may show a newer release later.	−USD 1.1 million Calculation and evidence -1096369 − 0 USD Exact free cash flow: -1096369 USD 2012-01-01 – 2012-12-31: -1096369 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bio-AMD Inc. · 2012-12-31 Bio-AMD Inc. (edgar:1370030) Free cash flow: -1096369 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1096369 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518514000677/biad-20131231.xml#153243 Filing: 000118518514000677 Input fundies:CapitalExpenditure: 0 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518514000677/biad-20131231.xml#153868 Filing: 000118518514000677 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 994,294 Exact value Exact value: -994294 USD 2013-01-01 – 2013-12-31: -994294 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-AMD Inc. · 2013-12-31 Bio-AMD Inc. (edgar:1370030) Net Income: -994294 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -994294 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518515002152/biad-20150630.xml#75062 Filing: 000118518515002152 The citation records this snapshot. The page link may show a newer release later.	−USD 1.02 million Exact value Exact value: -1018045 USD 2013-01-01 – 2013-12-31: -1018045 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-AMD Inc. · 2013-12-31 Bio-AMD Inc. (edgar:1370030) Operating Cash Flow: -1018045 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1018045 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518515000675/biad-20141231.xml#66236 Filing: 000118518515000675 The citation records this snapshot. The page link may show a newer release later.	USD 413 Exact value Exact value: 413 USD 2013-01-01 – 2013-12-31: 413 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bio-AMD Inc. · 2013-12-31 Bio-AMD Inc. (edgar:1370030) Capital Expenditure: 413 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 413 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518515000675/biad-20141231.xml#66635 Filing: 000118518515000675 The citation records this snapshot. The page link may show a newer release later.	−USD 1.02 million Calculation and evidence -1018045 − 413 USD Exact free cash flow: -1018458 USD 2013-01-01 – 2013-12-31: -1018045 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 413 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bio-AMD Inc. · 2013-12-31 Bio-AMD Inc. (edgar:1370030) Free cash flow: -1018458 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1018045 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518515000675/biad-20141231.xml#66236 Filing: 000118518515000675 Input fundies:CapitalExpenditure: 413 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518515000675/biad-20141231.xml#66635 Filing: 000118518515000675 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 1.13 million Exact value Exact value: -1131130 USD 2014-01-01 – 2014-12-31: -1131130 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-AMD Inc. · 2014-12-31 Bio-AMD Inc. (edgar:1370030) Net Income: -1131130 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1131130 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#54501 Filing: 000118518516004058 The citation records this snapshot. The page link may show a newer release later.	−USD 1.17 million Exact value Exact value: -1173247 USD 2014-01-01 – 2014-12-31: -1173247 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-AMD Inc. · 2014-12-31 Bio-AMD Inc. (edgar:1370030) Operating Cash Flow: -1173247 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1173247 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#70109 Filing: 000118518516004058 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2014-01-01 – 2014-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bio-AMD Inc. · 2014-12-31 Bio-AMD Inc. (edgar:1370030) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#660917 Filing: 000118518516004058 The citation records this snapshot. The page link may show a newer release later.	−USD 1.17 million Calculation and evidence -1173247 − 0 USD Exact free cash flow: -1173247 USD 2014-01-01 – 2014-12-31: -1173247 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bio-AMD Inc. · 2014-12-31 Bio-AMD Inc. (edgar:1370030) Free cash flow: -1173247 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1173247 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#70109 Filing: 000118518516004058 Input fundies:CapitalExpenditure: 0 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#660917 Filing: 000118518516004058 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 830,973 Exact value Exact value: -830973 USD 2015-01-01 – 2015-12-31: -830973 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-AMD Inc. · 2015-12-31 Bio-AMD Inc. (edgar:1370030) Net Income: -830973 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -830973 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#54377 Filing: 000118518516004058 The citation records this snapshot. The page link may show a newer release later.	−USD 254,973 Exact value Exact value: -254973 USD 2015-01-01 – 2015-12-31: -254973 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-AMD Inc. · 2015-12-31 Bio-AMD Inc. (edgar:1370030) Operating Cash Flow: -254973 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -254973 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#69887 Filing: 000118518516004058 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2015-01-01 – 2015-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bio-AMD Inc. · 2015-12-31 Bio-AMD Inc. (edgar:1370030) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#657529 Filing: 000118518516004058 The citation records this snapshot. The page link may show a newer release later.	−USD 254,973 Calculation and evidence -254973 − 0 USD Exact free cash flow: -254973 USD 2015-01-01 – 2015-12-31: -254973 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bio-AMD Inc. · 2015-12-31 Bio-AMD Inc. (edgar:1370030) Free cash flow: -254973 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:08:07Z Snapshot: f0c53c83ba1c4a87e6299ffbb259a735540c75768f943780920d7d5f41ef5daf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1370030?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -254973 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#69887 Filing: 000118518516004058 Input fundies:CapitalExpenditure: 0 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1370030/000118518516004058/biad-20151231.xml#657529 Filing: 000118518516004058 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

50 filings · 1,911 latest values · 1,911 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001370030, 1370030, edgar:1370030

Also known as Bio-AMD Inc., Flex Fuels Energy, Inc., Malibu Minerals Inc.

Bio-AMD Inc.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation